Project: Transcriptomic profiling of HIV-associated diffuse large B cell lymphoma; Developing lymphoma diagnostic pathways for low-resource settings; Defining and targeting MRD in Follicular Lymphoma.
katheriner_antel@dfci.harvard.edu
Project: Characterizing the spatial organization of tumor and immune cells in Peripheral T-Cell Lymphomas using high-plex imaging
(617)632-4245
Project: New therapeutics for high-risk lymphomas
(617)632-4245
Focus: Defining vulnerabilities of minimal residual disease (MRD) in B-cell lymphomas
(617) 632-4245
Project: Mouse models with ALK+ LBCL and Follicular lymphoma and novel therapeutic targets in B Cell Lymphomas
(617)632-4245
Project: CAR-T 37, Nascent Transcriptomics, Profiling PDXs
(617) 632-4245
Projects: Experimental Therapeutics in T-cell Lymphomas
(650) 224-0183
salvia.jain@mgh.harvard.edu
Project: : T-cell lymphoma characterization via nascent transcriptomic sequencing
(617) 632-4245
Projects: Mouse Models of ALL, Experimental Therapeutics in Xenograft Models
(617) 582-8867
Huiyun_Liu@dfci.harvard.edu
Projects: Genomics of Follicular Lymphoma, Signaling in Lymphoma
(617) 582–8866
ALouissaint@partners.org
Projects: Novel Targets in T-cell Lymphomas, Mouse Models of T-cell Transformation
(617) 582–9171
Project: Multi-dimensional characterization of lymphoma using single-cell sequencing, high-plex imaging and biophysical measurements to model the tumor microenvironment and identify novel therapeutic targets.
617-632-4245
Focus: Drug Resistance and Novel Targets in T-Cell Lymphomas
(617) 417-7958
Wenchao_Wu@dfci.harvard.edu
Focus: Novel Targets and Mechanisms in Lymphomas
(617) 632–4245
Project: Identification and characterization of minimal residual disease using single-cell sequencing and multiplex imaging for novel therapeutic targets in lymphomas
(617) 632-4245